within Pharmacolibrary.Drugs.ATC.D;

model D03BA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Trypsin is a serine protease enzyme primarily used in medicine for the debridement of wounds and ulcers, as well as in various digestive and anti-inflammatory preparations. It is derived from the pancreas and acts by breaking down proteins at the carboxyl side of lysine and arginine amino acid residues. Trypsin is approved in some countries for topical or enzymatic debridement, but systemic uses are limited due to rapid inactivation in blood.</p><h4>Pharmacokinetics</h4><p>No published studies report compartmental pharmacokinetics, bioavailability, volume of distribution, or clearance after systemic administration of trypsin in humans. Pharmacokinetic data are unavailable, as trypsin is typically administered topically or locally (e.g., wound application) with minimal systemic absorption.</p><h4>References</h4><ol><li><p>Thotakura, N, et al., &amp; Katare, P (2017). Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers. <i>Current drug metabolism</i> 18(5) 404–411. DOI:<a href=&quot;https://doi.org/10.2174/1389200218666170306104042&quot;>10.2174/1389200218666170306104042</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28266274/&quot;>https://pubmed.ncbi.nlm.nih.gov/28266274</a></p></li><li><p>Rowe, SM, et al., &amp; Waltz, DA (2013). Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis. <i>Chest</i> 144(1) 200–207. DOI:<a href=&quot;https://doi.org/10.1378/chest.12-2431&quot;>10.1378/chest.12-2431</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23412700/&quot;>https://pubmed.ncbi.nlm.nih.gov/23412700</a></p></li><li><p>Kahn, M, et al., &amp; Allansmith, MR (1990). Penetrating the conjunctival barrier. The role of molecular weight. <i>Investigative ophthalmology &amp; visual science</i> 31(2) 258–261. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2303328/&quot;>https://pubmed.ncbi.nlm.nih.gov/2303328</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D03BA01;
